Experimental blood test detects multiple dementia types with 92% accuracy
By
Michael Howerton
Crackling crust, pillowy middle. The kind of bagel that earns a second cup of coffee.
Summary
Researchers have developed an experimental blood test that measures 15 proteins to help diagnose four major neurodegenerative diseases — Alzheimer's, Parkinson's, frontotemporal dementia, and dementia with Lewy bodies. The test can detect if a person has more than one of these conditions with 92.3% accuracy, addressing the challenge of overlapping brain diseases that are difficult to distinguish, especially in early stages.
Key quotes
· 3 pulledWhen something goes wrong in the brain of people with dementia, often it's more than one thing.
The test measures the levels of 15 proteins in the blood to help diagnose four major neurodegenerative diseases — Alzheimer's, Parkinson's, frontotemporal dementia and dementia with Lewy bodies.
And it can determine if a person has more than one of those diseases with 92.3 percent accuracy.
You might also wanna read
Three-Minute Home Test Shows Promise for Early Alzheimer's Detection Years Before Traditional Diagnosis
Researchers have developed a three-minute take-home test called 'Fastball' that can identify symptoms linked to Alzheimer's disease years be
New MRI-Based Biomarker Predicts Aging and Disease Risks
Researchers from Duke University, Harvard University, and the University of Otago have developed DunedinPACNI, a noninvasive MRI-based bioma
insideprecisionmedicine.com·10mo ago
Monash University study finds copper-delivering drug Cu(ATSM) reduces Alzheimer's proteins and improves memory in lab tests
Monash University researchers have discovered that a copper-delivering drug called Cu(ATSM) significantly reduces toxic Alzheimer's proteins
Newborns have elevated levels of a biomarker for Alzheimer's
Virginia Tech Researchers Reverse Age-Related Memory Decline by Targeting Molecular Changes in Brain
Virginia Tech researchers conducted two studies on age-related memory decline, focusing on molecular changes in the brain. The first study e
Salk Institute Study Finds Cannabinoids May Help Remove Alzheimer's-Related Proteins from Brain Cells
Salk Institute researchers have found preliminary evidence that THC and other cannabinoids can promote the cellular removal of amyloid beta
salk.edu·3mo ago